|1.||Erdal, Mehmet Emin: 2 articles (11/2011 - 06/2011)|
|2.||Herken, Hasan: 2 articles (11/2011 - 06/2011)|
|3.||Thompson, Peter M: 2 articles (06/2003 - 05/2003)|
|4.||Beasley, Clare L: 1 article (09/2015)|
|5.||Dwork, Andrew J: 1 article (09/2015)|
|6.||Honer, William G: 1 article (09/2015)|
|7.||Rosoklija, Gorazd: 1 article (09/2015)|
|8.||Mann, J John: 1 article (09/2015)|
|9.||Ramos-Miguel, Alfredo: 1 article (09/2015)|
|10.||Barr, Alasdair M: 1 article (09/2015)|
|1.||Schizophrenia (Dementia Praecox)
10/05/2009 - "Synaptosomal Associated Protein 25 kDa (SNAP25) has been implicated in the pathogenesis of schizophrenia by numerous neuropathological studies and genetic variation at SNAP25 has been reported to be associated with ADHD. "
05/01/2003 - "In this study, the authors sought to replicate the findings of reduced synaptosomal associated protein 25 kDa (SNAP-25) immunoreactivity in the hippocampus of patients with schizophrenia. "
06/15/2003 - "We previously demonstrated increased synaptosomal associated protein, 25 kDa (SNAP-25), a member of the exocytotic mechanism, in the cerebrospinal fluid (CSF) of schizophrenia subjects. "
11/01/2008 - "Several post mortem studies revealed a reduction of SNAP-25 protein in the hippocampus of patients with schizophrenia and bipolar disorder (BD). "
09/15/2015 - "Synaptic dysfunction in schizophrenia may be associated with abnormal expression or function of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins (syntaxin, synaptosomal-associated protein 25 [SNAP25], vesicle-associated membrane protein [VAMP]) forming the molecular complex underlying neurosecretion. "
|2.||Personality Disorders (Personality Disorder)
|3.||Bipolar Disorder (Mania)
01/01/2013 - "Botulinum neurotoxin serotype A (BoNT/A) causes transient muscle paralysis by entering motor nerve terminals (MNTs) where it cleaves the SNARE protein Synaptosomal-associated protein 25 (SNAP25206) to yield SNAP25197. "
01/02/2014 - "BoNT/A application causes long-lasting flaccid paralysis of muscles through inhibiting the release of the neurotransmitter acetylcholine by cleaving synaptosomal-associated protein 25 (SNAP-25) within presynaptic nerve terminals. "
12/18/2012 - "Once inside cells, the zinc-dependent proteolytic light chain (LC) degrades specific proteins involved in acetylcholine release at neuromuscular junctions causing flaccid paralysis, specifically synaptosomal-associated protein 25 (SNAP-25) for botulinum neurotoxin type A (BoNT/A). "
|5.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/01/2002 - "Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population."
02/01/2012 - "Deficiencies or abnormal structure or function of SNAP25 protein, possibly arising through genetic variations in the relevant DNA code, has been suggested to play role in the pathology of several neurobehavioural disorders including Attention deficit Hyperactivity Disorder (ADHD) and a number of polymorphisms in the SNAP25 gene has been studied for association with the disorder. "
11/01/2011 - "To investigate the interaction of treatment-related hemodynamic changes with genotype status for Synaptosomal associated protein 25 (SNAP-25) gene in participants with attention deficit hyperactivity disorder (ADHD) on and off single dose short-acting methylphenidate treatment with functional near-infrared spectroscopy (fNIRS). "
|1.||Qa-SNARE Proteins (Syntaxin)
|2.||R-SNARE Proteins (Vesicle-Associated Membrane Protein)
|3.||SNARE Proteins (SNAREs)
|4.||Neurotransmitter Agents (Neurotransmitter)
|6.||Proteins (Proteins, Gene)
|7.||Acetylcholine (Acetylcholine Chloride)
|8.||Keratin-18 (Keratin 18)
|10.||Vesicle-Associated Membrane Protein 2 (VAMP2)